SCHEMBL21180775

SCHEMBL21180775

COC(=O)c1cc(NC(=O)c2cc(NC(=O)c3cc(N)cn3C)cn2C)cn1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY12 Q9H244 1/20 0.44
TOP1 P11387 2/20 0.44
HRAS P01112 1/20 0.44
ESR1 P03372 1/20 0.44
ESR2 Q92731 1/20 0.44
MAPT P10636 4/20 0.43
KDM4E B2RXH2 3/20 0.43
POLB P06746 1/20 0.43
HIF1A Q16665 1/20 0.43
PRKCA P17252 2/20 0.40
RXFP1 Q9HBX9 1/20 0.39
CYP1A2 P05177 3/20 0.38
CYP2C19 P33261 3/20 0.38
TP53 P04637 2/20 0.38
LMNA P02545 1/20 0.38
PKM P14618 1/20 0.37
HPSE Q9Y251 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26004856 1.00 P2RY12 (0.44) P2RY12TOP1HRASESR1ESR2
SCHEMBL12514045 1.00 P2RY12 (0.44) P2RY12TOP1HRASESR1ESR2
SCHEMBL14072132 0.91 P2RY12 (0.40) P2RY12TOP1HRASESR1ESR2
SCHEMBL24630354 0.87 HDAC1 (0.44) P2RY12TOP1HRASESR1ESR2
SCHEMBL13256738 0.87 HDAC1 (0.44) P2RY12TOP1HRASESR1ESR2
SCHEMBL24511102 0.87 TOP1 (0.37) P2RY12TOP1HRASESR1ESR2
SCHEMBL2215169 0.86 CYP1A2 (0.46) MAPTKDM4EPOLBCYP1A2CYP2C19
SCHEMBL20833653 0.86 P2RY12 (0.44) P2RY12TOP1HRASESR1ESR2
SCHEMBL20833642 0.86 P2RY12 (0.44) P2RY12TOP1HRASESR1ESR2
SCHEMBL20485567 0.85 HRAS (0.45) P2RY12TOP1HRASESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10358439-B2 DNA binding agents with a minor groove binding tail BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2019-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10358439-B2 DNA binding agents with a minor groove binding tail TOP2B, TOP2A, TOP1 P2RY12 3975/4885TOP1 3/4885HRAS 987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.